Market Place
Sourcing Support
Aadi Bioscience Closes Merger with Aerpio Pharma and $155M Private Placement
26 Aug 2021 //
GLOBENEWSWIRE
Aerpio Provides Update on Aadi Bioscience Presentation at the ASCO 2021
18 May 2021 //
GLOBENEWSWIRE
Aerpio Pharma and Aadi Bioscience Enter into a Definitive Merger Agreement
17 May 2021 //
BIOSPACE
Aerpio and Aadi Bioscience Enter into a Definitive Merger Agreement
17 May 2021 //
GLOBENEWSWIRE
Aerpio Announces Strategic Review after Topline Results from Razuprotafib
05 Jan 2021 //
GLOBENEWSWIRE
Aerpio Announces Statistically Significant Topline Results from Razuprotafib
11 Dec 2020 //
GLOBENEWSWIRE
Aerpio Hosting Key Opinion Leader Call on New Therapeutic Agents for COVID-19
05 Nov 2020 //
GLOBENEWSWIRE
Aerpio Announces First Patient Dosed with Razuprotafib in the Phase 2 Trial
26 Oct 2020 //
GLOBENEWSWIRE
Aerpio and Quantum Leap Announce First Patients Dosed in COVID Trial
01 Sep 2020 //
PRNEWSWIRE
Aerpio Announces a Second Trial with Funding from MTEC to Evaluate Razuprotafib
04 Aug 2020 //
GLOBENEWSWIRE
Aerpio Announces Initiation of 28-Day Phase 2 Razuprotafib Glaucoma Trial
24 Jun 2020 //
GLOBENEWSWIRE
Aerpio and Quantum Leap to study razuprotafib for ARDS in Covid-19
28 May 2020 //
CLINICALTRIALSARENA
Aerpio Pharmaceuticals and Quantum Leap Healthcare Collaborative Razuprotafib
27 May 2020 //
GLOBENEWSWIRE
Aerpio Pharma & Quantum Leap Healthcare Collaborative Announce of Razuprotafib
27 May 2020 //
PRNEWSWIRE
Aerpio Announces Amended Licensing Deal with Gossamer Bio on its (IBD) GB004
12 May 2020 //
BIOSPACE
Aerpio`s Presents Data f-Cohort Showing Topical Ocular Formulation of AKB-9778
10 Feb 2020 //
BUSINESSWIRE
Aerpio`s Presents Data f-Cohort Showing Topical Ocular Formulation of AKB-9778
10 Feb 2020 //
BUSINESSWIRE
Aerpio Presents Data of Topical Ocular Formulation of AKB-9778
07 Feb 2020 //
FORBES
Topical Ocular Formulation of Aerpio Pharmaceutical’s AKB-9778
08 Jan 2020 //
BUSINESS WIRE
Topical Ocular Formulation of Aerpio Pharmaceutical’s AKB-9778
08 Jan 2020 //
BUSINESS WIRE
Topical Ocular Formulation of Aerpio Pharmaceutical’s AKB-9778
07 Jan 2020 //
BUSINESS WIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.